MENU
CNS Pharmaceuticals (CNSP) Ownership - Who owns CNS Pharmaceuticals?
Profile
Industry
N/A
Address
2100 West Loop South
Phone
+1 800 946-9185
Employees
5
Web
https://www.cnspharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.82M
P/E Ratio
N/A
Total Cash
1.49M
Projected Growth
N/A
Total Debt
123.25K
Revenue
N/A
Risk (Beta)
-0.01
Dividend Yield
N/A
Total Cash/Share
0.05
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CNSP
Capitalization
4.82M
P/E Ratio
N/A
Risk (Beta)
-0.01
Dividend Yield
N/A
Total Cash
1.49M
Total Cash/Share
0.05
Total Debt
123K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-4.29M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-367.38
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.44K
Current Ratio
0.32
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-15.95M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-358.12
Shares Held By Institutions
294K
Shares Outstanding - Current
32.1M
Total Liabilities
6.76M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-99.764
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2100 West Loop South
Phone
+1 800 946-9185
Employees
5
Web
https://www.cnspharma.com